Methods of displaying the antimicrobial sensitivity of biological isolates

US11264118B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11264118-B2
Application numberUS-201615557628-A
CountryUS
Kind codeB2
Filing dateMar 10, 2016
Priority dateMar 12, 2015
Publication dateMar 1, 2022
Grant dateMar 1, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and systems for monitoring and determining antimicrobial resistance and antimicrobial treatment using genomic subtype information. Various embodiments utilize molecular epidemiology and next-generation sequencing technologies (NGS) to monitor multi-drug resistant pathogens and provide early insight into emergent microbial threats.

First claim

Opening claim text (preview).

What is claimed is: 1. A computer-implemented method for generating a subtype-specific display, the method comprising: providing a computer processor configured to: (a) receive information concerning the sensitivity of at least one isolate to at least one antimicrobial; (b) receive information concerning the genomic subtype of the at least one isolate; and (c) provide a graphical display of at least one number representative of the sensitivity of the at least one isolate to an antimicrobial, the isolates organized by genomic subtype. 2. The computer-implemented method of claim 1 wherein receiving information concerning the genomic subtype of the at least one isolate comprises: (a) receiving data describing at least part of the genome of the at least one isolate; (b) comparing the received genomic data from the sequencing operation against a reference database; and (c) identifying a matching genomic subtype for the at least one isolate from the results of the comparison. 3. The computer-implemented method of claim 1 wherein receiving information concerning the sensitivity of the at least one isolate to at least one antimicrobial comprises receiving the results of an antimicrobial sensitivity test for the at least one isolate utilizing the at least one antimicrobial. 4. The computer-implemented method of claim 1 wherein providing a graphical display of the sensitivity of the at least one isolate to the at least one antimicrobial organized by genomic subtype comprises providing a graphical display in a matrix configuration with each row associated with one genomic subtype and each column associated with one antimicrobial. 5. The computer-implemented method of claim 1 wherein providing a graphical display of the sensitivity of the at least one isolate to the at least one antimicrobial organized by genomic subtype comprises providing a graphical display in a matrix configuration with each column associated with one genomic subtype and each row associated with one antimicrobial. 6. The computer-implemented method of claim 1 wherein providing a graphical display of the sensitivity of the at least one isolate to the at least one antimicrobial organized by genomic subtype comprises providing a graphical display of colored items in a matrix configuration. 7. The computer-implemented method of claim 1 wherein providing a graphical display of at least one number representative of the sensitivity of the at least one isolate to the antimicrobial comprises providing a graphical display of numbers in a column. 8. The computer-implemented method of claim 1 wherein each number is the prevalence of that isolate genomic subtype in a population in a particular timeframe and the sensitivity ratio for that isolate genomic subtype is displayed as a color or a shaded circle. 9. The computer-implemented method of claim 1 wherein each number is an average sensitivity for a plurality of isolates of a particular genomic subtype against a particular antimicrobial. 10. The computer-implemented method of claim 1 wherein each number is the sensitivity-to-resistance ratio for a genomic subtype against an antimicrobial. 11. A non-transitory machine-readable medium containing computer-executable instructions for performing a method for generating a subtype-specific display, the medium comprising: (a) computer-executable instructions for receiving information concerning the sensitivity at least one isolate to at least one antimicrobial; (b) computer-executable instructions for receiving information concerning the genomic subtype of the at least one isolate; and (c) computer-executable instructions for providing a graphical display of at least one number representative of the sensitivity of the at least one isolate to an antimicrobial, the isolates organized by genomic subtype. 12. The non-transitory machine-readable medium of claim 11 wherein the computer-executable instructions for receiving information concerning the genomic subtype of the at least one isolate comprise: (a) computer-executable instructions for receiving data describing at least part of the genome of the at least one isolate; (b) computer-executable instructions for comparing the received genomic data from the sequencing operation against a reference database; and (c) computer-executable instructions for identifying a matching genomic subtype for the at least one isolate from the results of the comparison. 13. The non-transitory machine-readable medium of claim 11 wherein the computer-executable instructions for receiving information concerning the sensitivity of the at least one isolate to at least one antimicrobial comprise computer-executable instructions for receiving the results of an antimicrobial sensitivity test for the at least one isolate utilizing the at least one antimicrobial. 14. The non-transitory machine-readable medium of claim 11 wherein the computer-executable instructions for providing a graphical display of at least one number representative of the sensitivity of the at least one isolate to the antimicrobial comprise computer-executable instructions for providing a graphical display in a matrix configuration with each row associated with one genomic subtype and each column associated with one antimicrobial. 15. The non-transitory machine-readable medium of claim 11 wherein the computer-executable instructions for providing a graphical display of at least one number representative of the sensitivity of the at least one isolate to the antimicrobial comprise computer-executable instructions for providing a graphical display in a matrix configuration with each column associated with one genomic subtype and each row associated with one antimicrobial.

Assignees

Inventors

Classifications

  • G16B45/00Primary

    ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks · CPC title

  • Testing for antimicrobial activity of a material · CPC title

  • Locking mechanisms for points; Means for indicating the setting of points · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11264118B2 cover?
Methods and systems for monitoring and determining antimicrobial resistance and antimicrobial treatment using genomic subtype information. Various embodiments utilize molecular epidemiology and next-generation sequencing technologies (NGS) to monitor multi-drug resistant pathogens and provide early insight into emergent microbial threats.
Who is the assignee on this patent?
Koninklijke Philips Nv
What technology area does this patent fall under?
Primary CPC classification G16B45/00. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).